For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Pre-surgical Erlotinib Treatment | Erlotinib 150 mg by mouth daily for 3 weeks followed by cystectomy within 24 hours of the last dose. | 0 | None | 5 | 31 | 19 | 31 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V3.0 | View |
| Decreased Neutrophils/Grabulocytes | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE V3.0 | View |
| Adrenal insufficiency | SYSTEMATIC_ASSESSMENT | Endocrine disorders | NCI CTCAE V3.0 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE V3.0 | View |
| Infection-wound | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE V3.0 | View |
| Decreased Leukocytes (Total WBD) | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE V3.0 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE V3.0 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE V3.0 | View |
| Lymphopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE V3.0 | View |
| Decreased Neutrophils/Grabulocytes | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE V3.0 | View |